Abstract:Background: Story recall is a simple and sensitive cognitive test that is commonly used to measure changes in episodic memory function in early Alzheimer disease (AD). Recent advances in digital technology and natural language processing methods make this test a candidate for automated administration and scoring. Multiple parallel test stimuli are required for higher-frequency disease monitoring. Objective: This study aims to develop and validate a remote and fully automated story recall task, suitable for longitudinal assessment, in a population of older adults with and without mild cognitive impairment (MCI) or mild AD. Methods: The "Amyloid Prediction in Early Stage Alzheimer's disease" (AMYPRED) studies recruited participants in the United Kingdom (AMYPRED-UK: NCT04828122) and the United States (AMYPRED-US: NCT04928976). Participants were asked to complete optional daily self-administered assessments remotely on their smart devices over 7 to 8 days. Assessments included immediate and delayed recall of 3 stories from the Automatic Story Recall Task (ASRT), a test with multiple parallel stimuli (18 short stories and 18 long stories) balanced for key linguistic and discourse metrics. Verbal responses were recorded and securely transferred from participants' personal devices and automatically transcribed and scored using text similarity metrics between the source text and retelling to derive a generalized match score. Group differences in adherence and task performance were examined using logistic and linear mixed models, respectively. Correlational analysis examined parallel-forms reliability of ASRTs and convergent validity with cognitive tests (Logical Memory Test and Preclinical Alzheimer's Cognitive Composite with semantic processing). Acceptability and usability data were obtained using a remotely administered questionnaire. Results: Of the 200 participants recruited in the AMYPRED studies, 151 (75.5%)-78 cognitively unimpaired (CU) and 73 MCI or mild AD-engaged in optional remote assessments. Adherence to daily assessment was moderate and did not decline over time but was higher in CU participants (ASRTs were completed each day by 73/106, 68.9% participants with MCI or mild AD and 78/94, 83% CU participants). Participants reported favorable task usability: infrequent technical problems, easy use of the app, and a broad interest in the tasks. Task performance improved modestly across the week and was better for immediate recall. The generalized match scores were lower in participants with MCI or mild AD (Cohen d=1.54). Parallel-forms reliability of ASRT stories was moderate to strong for immediate recall (mean rho 0.73, range 0.56-0.88) and delayed recall (mean rho=0.73, range=0.54-0.86). The ASRTs showed moderate convergent validity with established cognitive tests. Conclusions: The unsupervised, self-administered ASRT task is sensitive to cognitive impairments in MCI and mild AD. The task showed good usability, high parallel-forms reliability, and high convergent validity with established cognitive tests. Remote, low-cost, low-burden, and automatically scored speech assessments could support diagnostic screening, health care, and treatment monitoring.

A remote speech-based AI system to screen for early Alzheimer's disease via smartphones

Identification of Alzheimer's Disease Patients Based on Oral Speech Features

Digitized Biomarkers Utilizing Human‐Computer Interaction Sensing Technology for Early Auxiliary Diagnosis of Alzheimer’s Disease

Leveraging speech and artificial intelligence to screen for early Alzheimer’s disease and amyloid beta positivity

Artificial Intelligence-Enabled End-To-End Detection and Assessment of Alzheimer's Disease Using Voice

Prediction of Alzheimer's disease progression within 6 years using speech: A novel approach leveraging language models

Storyteller in ADNI4: Application of an early Alzheimer's disease screening tool using brief, remote, and speech-based testing

Validation of a Remote and Fully Automated Story Recall Task to Assess for Early Cognitive Impairment in Older Adults: Longitudinal Case-Control Observational Study

An explainable machine learning model of cognitive decline derived from speech

Automated Classification of Cognitive Decline and Probable Alzheimer's Dementia Across Multiple Speech and Language Domains

Speech based detection of Alzheimer's disease: a survey of AI techniques, datasets and challenges

ADscreen: A speech processing-based screening system for automatic identification of patients with Alzheimer's disease and related dementia

Screening over Speech in Unselected Populations for Clinical Trials in AD (PROSPECT-AD): Study Design and Protocol

Artificial Intelligence, speech and language processing approaches to monitoring Alzheimer's Disease: a systematic review

Screening for early Alzheimer’s disease: enhancing diagnosis with linguistic features and biomarkers

Screening for early Alzheimer's disease: enhancing diagnosis with linguistic features and biomarkers

Exploiting Longitudinal Speech Sessions via Voice Assistant Systems for Early Detection of Cognitive Decline

Digital remote assessment of speech acoustics in cognitively unimpaired adults: feasibility, reliability and associations with amyloid pathology

Development of a smartphone screening test for preclinical Alzheimer's disease and validation across the dementia continuum

A novel speech analysis algorithm to detect cognitive impairment in a Spanish population

Detection of Mild Cognitive Impairment Through Natural Language and Touchscreen Typing Processing